US Patent 11479610 Anti-IL1RAP antibody
Patent 11479610 was granted and assigned to Cantargia on October, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 22, 2021
Date of Patent
October 25, 2022
Patent Applicant
Patent Application Number
17559227
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11479610 Anti-IL1RAP antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.